Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean J Pittock

Showing results (21-30 of 459) with videos related to

Pageof 46
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 13, 2022
Anti-complement Agents for Autoimmune Neurological DiseaseJennifer A McCombe, Sean J Pittock
Current Opinion in Neurology|August 18, 2006
Inflammatory transverse myelitis: evolving conceptsSean J Pittock, Claudia F Lucchinetti
JAMA Neurology|July 14, 2015
Rituximab Therapy in Neuromyelitis Optica: Moving Toward a Personalized Medicine ApproachW Oliver Tobin, Sean J Pittock
Annals of the New York Academy of Sciences|June 23, 2015
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade laterSean J Pittock, Claudia F Lucchinetti
Archives of Neurology|May 14, 2008
Aquaporin-4 autoantibodies in a paraneoplastic contextSean J Pittock, Vanda A Lennon
Archives of Neurology|July 11, 2012
Cutting-edge questions about CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids)B Mark Keegan, Sean J Pittock
Neurology|April 28, 2012
Emerging synaptic biomarkers in autoimmune dementia: NMDARs targeted by IgASean J Pittock, Rita Balice-Gordon
Continuum (Minneapolis, Minn.)|June 2, 2017
Autoimmune Neurology of the Central Nervous SystemW Oliver Tobin, Sean J Pittock
The Neurologist|March 14, 2007
The pathology of MS: new insights and potential clinical applicationsSean J Pittock, Claudia F Lucchinetti
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 5, 2012
Do not treat from CIS onset: evaluate disease course and prognosis first--yesReem F Bunyan, Sean J Pittock
Pageof 46

Showing results (21-30 of 459) with videos related to

Sort By:
Pageof 46
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 13, 2022
Anti-complement Agents for Autoimmune Neurological DiseaseJennifer A McCombe, Sean J Pittock
Current Opinion in Neurology|August 18, 2006
Inflammatory transverse myelitis: evolving conceptsSean J Pittock, Claudia F Lucchinetti
JAMA Neurology|July 14, 2015
Rituximab Therapy in Neuromyelitis Optica: Moving Toward a Personalized Medicine ApproachW Oliver Tobin, Sean J Pittock
Annals of the New York Academy of Sciences|June 23, 2015
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade laterSean J Pittock, Claudia F Lucchinetti
Archives of Neurology|May 14, 2008
Aquaporin-4 autoantibodies in a paraneoplastic contextSean J Pittock, Vanda A Lennon
Archives of Neurology|July 11, 2012
Cutting-edge questions about CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids)B Mark Keegan, Sean J Pittock
Neurology|April 28, 2012
Emerging synaptic biomarkers in autoimmune dementia: NMDARs targeted by IgASean J Pittock, Rita Balice-Gordon
Continuum (Minneapolis, Minn.)|June 2, 2017
Autoimmune Neurology of the Central Nervous SystemW Oliver Tobin, Sean J Pittock
The Neurologist|March 14, 2007
The pathology of MS: new insights and potential clinical applicationsSean J Pittock, Claudia F Lucchinetti
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 5, 2012
Do not treat from CIS onset: evaluate disease course and prognosis first--yesReem F Bunyan, Sean J Pittock
Pageof 46